Labome lists 566997 antibody products against 58324 genes, including 18816 human, 14158 mouse, and 12188 rat genes.
This is a summary of AF488 antibody products in Labome database. There are 3514 monoclonal AF488 antibody products, 115 polyclonal AF488 antibody products, 16 recombinant AF488 antibody products, including AF488 conjugated antibodies against 1468 human genes.
If you are looking for AF488 conjugated antibodies against a specific gene, type in gene name in the box above and search. In the resultant gene webpage, select 'antibody' link for the correct gene to go to the antibody webpage, and use the AF488 filter there to obtain a list of AF488 conjugated antibodies for that gene.
Labome product database lists 3514 monoclonal AF488 conjugated antibodies, 115 polyclonal AF488 conjugated antibodies, 16 recombinant AF488 conjugated antibodies.
AF488 conjugated antibodies correspond to 1468 human genes, 601 mouse genes, 221 rat genes, 62 dogs genes, 59 rhesus macaque genes, 44 bovine genes, 24 chimpanzee genes, 22 domestic rabbit genes, 18 pigs
In Labome product database, among AF488 conjugated antibodies, 1801 from mouse host, 1038 from domestic rabbit host, 626 from rat host, 60 from hamsters host, 50 from domestic goat host, 27 from human host, 17 from domestic sheep host.
In Labome product database, among AF488 conjugated antibodies, 35 products are against phosphorylated antigens.
In Labome product database, among AF488 conjugated antibodies, 2928 can be used for FC, 1074 can be used for IC, 187 can be used for IHC-P, 157 can be used for IHC, 144 can be used for IHC-F, 92 can be used for WB, 47 can be used for IP, 21 can be used for ELISA, 6 can be used for dot, 5 can be used for MC, 3 can be used for ChIP, 2 can be used for EMSA.
- we limit the listing of re-branded antibodies to provide our visitors with accurate information and the best experience
- we manually curate antibody information from the literature to obtain a comprehensive set of well-validated antibodies.
- we limit citation information for polyclonal antibodies to articles published within the last 5 years because the supply of a particular polyclonal antibody preparation is limited.
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.